Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover

ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS

Ludmila P. Alexeeva, Patrick Burkhardt, C. Christiansen et al. · 1994 · 2.7K citations

Medicine, Orthopedic Surgery, Preventive Medicine +10

Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength

Charles A. O’Brien, Dan Jia, Lilian I. Plotkin et al. · Endocrinology · 2003 · 766 citations · Full text

Medicine, Endocrinology, Apoptosis +16

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 550 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Ji Li, Ildiko Sarosi, Russell C. Cattley et al. · Bone · 2006 · 434 citations

Medicine, Orthopedic Surgery, Bone Metabolism +11

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

Ulrike I. Mödder, Kelley A. Hoey, Shreyasee Amin et al. · Journal of Bone and Mineral Research · 2010 · 394 citations · Full text

Medicine, Endocrinology, Aging +11